Vice-President, Business Development at Healthcare Capital and Mergers, LLC
Dale Benzine has been in the medical equipment/supply business for more than 30 years operating, acquiring and assisting in the development of over 100 medical equipment/service companies. He currently serves as a Vice-President of Business Development at Healthcare Capital and Mergers, LLC a 25 year old Chicago- based investment banking firm specializing in assisting small to medium size healthcare firms. He most recently served as the CEO/President/Co-owner of Priority Medical, a medical supply business specializing in respiratory care. Priority Medical was acquired by Dale in 2013. From 2005 thru 2012, Dale served as CEO/President and owner of Serenity Medical, LLC d/b/a Diabetexs and later ProMed. Both companies were medical supply businesses, Diabetexs was sold to Liberty Medical in May, 2010. ProMed was merged into Priority Medical on July 1, 2013. Dale founded Trinity Healthcare, Inc. in 1995. Trinity is a leading regional home infusion/respiratory therapy equipment/supply company based in Marietta, GA. Dale sold it to Arcadia Resources, Inc. (AMEX: KAD) in 2002.
Executive Chairman Orthotic Holdings
Mr. Sabel earned a Bachelor of Science degree in orthotics and prosthetics from New York University in 1967. Mr. Sabel was founder and president of Capital Orthopedics from 1968 to 1986 where he was a practicing certified prosthetist and orthotist. He had relationships with the National Institutes of Health, was on the faculty as an adjunct professor of orthopedics at Georgetown University and a clinical instructor in the prosthetic and orthotic program at New York University. Mr. Sabel co-authored numerous studies in the prosthetic field in conjunction with the National Institutes of Health. Hanger Orthopedic Group acquired Mr. Sabel’s company in 1986 and he became the Vice President of Corporate Development. The following year he was promoted to President and Chief Operating Officer and in 1995, was named Chairman and Chief Executive Officer. In February 2008, Mr. Sabel retired as Chief Executive Officer and has served as the Chairman of Hanger Orthopedic Group, Inc. (NYSE:HGR) until May 2013. Mr. Sabel led Hanger’s growth from $1.25 million in 1986 to over $1 billion today. Mr. Sabel is the Founder and Chairman of the Hanger – Ivan R. Sabel Foundation, a non-profit entity that provides prosthetic and orthotic services to people in need around the world. The Foundation currently has a major presence in Haiti following the disaster earthquake in January, 2010. Mr. Sabel serves as a member of the Board of Directors for Children’s Hospital – Washington, DC, Physician’s for Peace and is the Chairman of New York University Steinhardt Dean’s Council. In April 2012, Mr. Sabel joined Frazier Healthcare Ventures as an operating partner and following the acquisition of Orthotic Holdings, Inc., he was appointed chief executive officer.
RehabPulse Advisor for Payor Contracts
Senior health care executive with more than 30 years experience in a broad range of health markets and products. Experience includes P/L responsibility for group health, ancillary products, worker’s compensation and demand /disease management business units in Fortune 100 companies. Proven leadership strengths in strategy development, operations (including re-engineering and turnaround), provider networks, marketing/sales and information systems management. Demonstrated ability to improve top and bottom line growth in competitive health care environment.
Mahesh brings over twenty years of leadership experience including serving as CEO for venture and private-equity backed companies across multiple sectors. Mahesh is currently CEO for WillowWood, the third largest manufacturer of prosthetic medical devices in the US. Mahesh also served for five years as President of Össur, the second largest global manufacturer of non-invasive orthopedic and prosthetic devices. Outside of medical device, Mahesh served as CEO for sBioMed (infection control start-up) and REPOWER America, one of the top-ten providers of residential solar in the US. Prior to this, Mahesh worked at DuPont for six years, where he was General Manager for DuPont Tyvek, a $1.1B global business unit. Mahesh read for his MBA at Yale University and completed post-graduate studies at Warwick University Business School and Reading University in the UK.
Managing Director of CG Ventures
Doug McCormack has spent the past 25 years engaged at the intersection of health care policy, law, politics and business. He currently is Managing Director of CG Ventures, which assists a range of early stage companies in its portfolio. For the past ten years, Mr. McCormack has been founder, CEO and Chairman of three venture-backed technology companies – two in the medical device and digital health sectors and one focused on military ground robotics. Under his leadership, these companies secured over two dozen patents, were recognized with multiple R&D 100 and Edison Awards for innovation, and partnered with technology leaders, such as Apple, to feature the first medical device brought to market with patient connectivity and control via an iPhone app. Doug was named a Fierce Medical Devices 2013 Fierce 15 emerging CEOs to watch in medical devices. Mr. McCormack exited his first business, Orthocare Innovations, LLC, through a strategic asset sale to global market leader Otto Bock Health Care GMBH. He remains a board member of the digital health company he founded, Modus Health, LLC. Mr. McCormack was called on by the U.S. Department of Defense to leverage his expertise in assistive technology to serve as an appointee to the Defense Health Board to advise military medicine on its response to traumatic limb injuries and subsequent rehabilitation resulting from battlefield injuries during the war efforts in Iraq and Afghanistan. This effort included establishment of the rehabilitation capabilities through centers at Walter Reed Army Medical Center and the Center for the Intrepid in San Antonio. Prior to his entrepreneurial career, Doug spent fifteen years in policy and advocacy, including as a lawyer in a top DC-based law firm (Arent Fox), and then as a partner in a global law firm where he was a co-founder of that firm’s public policy and advocacy practice group (SNR Dentons, now Dentons). In this capacity, he focused on representing before the Congress and federal agencies a range of technology and health care interests, including medical technology companies, and venture fund investments. He remains engaged in the policy space through CG Ventures’ portfolio company Linchpin Strategies, LLC, for which he serves as Vice Chairman. In addition to serving as an advisory board member for ROWHEELS, Mr. McCormack serves as an industry advisor for Silverwood Partners, a boutique investment bank. Doug received his undergraduate degree from the University of Southern California and his Juris Doctorate from American University’s Washington College of Law. He is a member of the Maryland and District of Columbia bars, and serves on the boards and advisory boards of several early-stage technology companies